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Background: Home (HBPM) and ambulatory (ABPM) blood pressure measurements have their advantages and
disadvantages in diagnosing and managing hypertension. We studied HBPMs and ABPMs in volunteers taking part
in a survey.
Methods: Of 366 respondents, 270 provided a total of 5997 triplicate HBPMs (Part 1); 175 also provided data on
ABPMs, of which the measurements obtained between 6 am and 10 pm were used in this study (Part 2).
Results: Part 1, When all 5997 triplicate HPPMs were considered, 1st readings tended to be significantly higher
than those of the 2nd and 3rd for both, systolic and diastolic pressures, but when the consideration was restricted
to the very first triplicate of each of the 270 subjects, this was true only for systolic HBPM. Part 2, The ABPMs
tended to have a wider range than the corresponding HBPMs, and to be distributed towards higher values. Of the
non-parametric indices of (ABPM - corresponding HBPM), (First Quartile, Median, Third Quartile and Maximim) all
but the minima had positive values.
Conclusions: In triplicate HBPMs, the first measurement is usually but not always the highest. Increasing the
number of triplicates provided by each subject increases the chance of discriminating between measurements in
the triplicates. ABPMs tended to be higher than the corresponding HBPMs.
Keywords: Ambulatory blood pressure measurements, Home-based self measurementsBackground
There is little point nowadays in simply classifying people
as “hypertensive” or “non-hypertensive” purely on the basis
of one blood pressure measurement - no matter by what
means or how confidently it may have been made. For
some applications (for example, in monitoring or research-
ing the effect of antihypertensive medication on blood pres-
sure) it is important to be confident about baselines and
the changes that may occur with medication. For other ap-
plications such as assessing cardiovascular risk, additional
factors are at least as important as the blood pressure
measurement and choice of the means by which blood
pressure is measured may be less critical.
Home and ambulatory blood pressure measurements
(HBPMs, ABPMs) have their advantages and disadvan-
tages in diagnosing and managing hypertension. Subjects* Correspondence: sigrun.chrubasik@klinikum.uni-freiburg.de
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article, unless otherwise stated.who are taught to use the devices can carry out HBPMs,
away from many of the disturbances present in clinical
settings, but the time and effort required of the subject
place a limit on the number and timing of the measure-
ments that can be made. This is irrespective of recom-
mendations made in various guidelines [1-4]. ABPM was
establied before HBPM. It can be carried out with little
effort on the part of the subject other than to try not to
disturb the measurement and can be repeated at rela-
tively short intervals but resource limitations mean that
ABPM is usually restricted to no more than 24 hours at
a time. ABPM has been advocated as a gold standard [5]
for determining whether a subject needs to be started on
antihypertensive management or to have the manage-
ment changed. However, it is less feasible for monitoring
the time-course of any response to that treatment.
We have used data from a blood pressure screening
program in order to examine:ioMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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HBPMs for distinguishing the first measurement in a
triplicate from the second and third;
(ii) The difference between ABPM and HBPM in the
same subject.
Methods
The protocol for this single-centre surveillance study
was approved by the Committee for Human Ethics of
the Kanton Luzern/Switzerland. The study was adver-
tised locally by word of mouth and by flyers distributed
in the hospital, inviting would-be participants to contact
the Department “Arbeitsmedizinischer Dienst” of the
Kantonsspital Luzern. Exclusion criteria included a need
for immediate antihypertensive treatment, angina pec-
toris, atrial arrhythmia, vitium cordis with haemodynae-
mic impairment, chronic renal or liver diseases and
actual or contemplated pregnancy. After written in-
formed consent and assessments of baseline conditions
with a standardized questionnaire, blood pressure was
measured by the staff using a boso-medicus PC oscillo-
metric device validated according to the AAMI and
BHS protocol (grading A/A), Bosch + Sohn GmbH u.
Co KG, Jungingen (data of the validations are placed on
www.uniklinik-freiburg.de/rechtsmedizin/forschung/
phytomedizin.html, details to original articles).
(i) Participants were then shown how to measure their
own blood pressure correctly. Standard size 12 cuffs
were used except in patients whose arm
circumference exceeded 33 cm, for whom size 15
cuffs were used. They were asked to try to undertake
HBPMs three times a day (morning, lunch time,
evening) for the surveillance period. Each
measurement was to be made in triplicate, 2 minutes
apart, after resting seated for at least 10 minutes, and
at least 2 hours after any coffee or smoking. Heart rate
was recorded simultaneously. Seven to 10 days later,
the HBPM profile was printed out.
(ii) Those participants whose HBPM exceeded 125/
80 mmHg on average over the surveillance period
were invited to participate in a comparison of
ABPM and HBPM. The ABPMs were made on the
same arm as for the HBPM, using boso TM-2430
PC oscillometric devices. These devices, graded A/A,
(best category for systolic and diastolic measures),
were validated according to the protocol of the
Advancement of Medical Instrumentation and
British Hypertension Societies. ABPMs were made
every 15 min from 6 am to 10 pm and participants
were asked to try to keep the arm still during each
measurement. (ABPMs were also made every 30 min
from 10 pm to 6 am, but these are not considered in
this paper). After the 24 hours of recording, theparticipant returned to the “Arbeitsmedizinischer
Dienst” with a record of his or her activities of the
day and the quality of the night’s rest. The data were
transferred to the software boso-profilmanager 2
(descriptions of the handling of the devices and data
transfer are placed on the above mentioned website).
Statistical analysis was carried out using the UNIVARI-
ATE, NPAR1WAY and CORR procedures in SAS 9.2,
and the figures were plotted using Microsoft Excel.
For a subsidiary investigation into whether there was a
gender-related difference in median HBPM in the 347
patients who supplied an adequate number of readings,
we used the Multiple Regression procedure in Microsoft
Excel to regress participants’ ages, weights, heights and a
dummy variable for gender against the median HBPM.
We also did it for the 175 participants who were selected
by the blood pressure criterion of 125/85 for the com-
parison between HBPM and ABPM.
Results
Part 1: Triplicate home blood pressure measurements
The characteristics recorded for the 366 consecutively re-
cruited participants are summarised in Table 1. Of these,
96 were excluded because they failed to follow instructions
to make 3 triplicate HBPMs per day and/or contributed
fewer than 27 measurements in total (Figure 1). The
remaining 270 participants provided 5997 triplicates, − an
average of 22.2 triplicates (out of a maximum of 30) per
participant. Table 2 indicates the distributions of values of
systolic and diastolic HBPM and heart rate (HR) for the
1st, 2nd and 3rd values in the total of 5997 triplicates.
Table 3 indicates the corresponding distributions for the
1st triplicate contributed by each of the 270 participants.
Friedman testing on the data from all triplicates (Table 2
indicated differences, significant at the p < 0.001 level, be-
tween the 1st and second and the 1st and 3rd readings.
The general rule was that 1st systolic and diastolic HBPM
and HRs were greater than the 2nd and 3rd values, but
there was sufficient variability for the general rule to be in-
applicable in about one third of the triplicates.
When all participants were considered, maleness was as-
sociated with a significantly higher median HBPM than fe-
maleness, even when age, height and weight were allowed
for, but this was not so for the 175 patients who were se-
lected for ABPMs. In the sample of 347 participants pa-
tients, the ratio of males to females was 1.012:1. In the
sample of 175 selected by the blood pressure criterion, the
ratio was 1.1875 to 1. Details are given on the webpage.
Part 2: Comparison of ambulatory and home blood
pressure measurements
Of the participants whose average HBPM exceeded 125/
80, 175 had reasonably complete BPM sets with a mean
Table 1 The characteristics recorded from the 366 volunteers who responded to the publicity about the study
Mean SD
Age men (years) 52 (13)
Age women (years) 53 (14)
BMI men (kg/m2) 27 (5)
BMI women (kg/m2) 25 (5)
Numbers and percentages of patients: N (%)
Male: female: 179:187 (49:51)
With triplicate measurements 270 (74)
With mean home blood pressure measurement > 125/80 200 (54)
With family history of cardiovascular disease: 107 (29)
Current smokers 150 (41)
Sports activities > 20 min/day: 119 (33)
Previous myocardial infarction: 8 (2)
Angina pectoris: 6 (2)
Previous bypass surgery: 2 (1)
Previous percutaneous transluminal coronary angioplasty 9 (2)
Previous stroke 8 (2)
Subjected to salt restriction: 80 (22)
Numbers taking antihypertensive medications 97 (27)
Mean SD
Dose of antihypertensive agentss expressed as equivalents: 1.8 (1.5)
1 equivalent = hydrochloro thiazide 25 mg = enalapril 5 mg = lorsartan 50 mg
= metoprolol 100 mg = amlodipine 5 mg = isosorbide dinitrite 40 mg
= doxazozine 2 mg = clonidine 15 mg
Numbers taking medications for other reasons
Contraception: 14 (4)
Menopausal symptoms 20 (5)
Insulin: 4 (1)
Anti-diabetics: 13 (4)
Low-dose aspirin 31 (8)
Magnesium supplementation: 72 (20)
Anti-inflammatory drugs (NSAIDs): 15 (4)
Mean SD
Dose of NSAIDs expressed as diclofenac equivalents: 94 (61)
diclofencac 100 mg =metamizol 1330 mg = acetylsalicylic acid 1300 mg
= ibuprofen 800 mg = naproxen550 mg = propyphenazone 250 mg
= acemetacine 120 mg = ketoprofen 66.6 mg = indomethacin 50 mg
= piroxicam 6.66 mg.
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per participant and 63 systolic ABPM daytime readings
(Figure 1).
The distributions of the HBPMs over up to 10 days and
of ABPMs over up to 18 hours were compared in terms of
their minimum, 1st, 2nd and 3rd quartile, and maximum
values. The five indices of ABPM were plotted against thecorresponding indices of HBPM in Figure 2. The minima
are scattered mostly below the line of equality, but without
much adherence to its slope. The first quartile, median
and third quartile adhere quite well to the slope of the line
of equality, the first quartile being closest to it and the me-
dian and third quartile being displaced progressively above
it. The maxima are scattered, mostly above the line of
Figure 1 Flow chart of the in- and excluded participants.
Table 3 HBPM (mmHg) and heart rate (beats/min) of the
very first triplicate (first morning triplicate) for each
subject (n = 270)
Variable Mean SD Minimum Maximum
Systolic_1st 127 19 90 234
Systolic_2nd 123 17 87 195
Systolic_3rd 123 16 87 184
Diastolic_1st 80 14 41 203
Diastolic_2nd 79 11 44 128
Diastolic_3rd 79 11 52 128
Heart rate_1st 68 10 44 106
Heart rate_2nd 66 10 46 105
Heart rate_3rd 66 10 41 104
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correlation coefficients show a modest correlation be-
tween the respective first quartiles, medians and third
quartiles, but weak correlation between the minima and
maxima. The dotted rectangles enclose the ranges ABPM
(vertical) and HBPM (horizintal) observations in each plot.
They are not strikingly different between plots and be-
tween ABPM and HBPM.
Further data on the distributions of ABPM and HBPM
in terms of the median values of their five indices of distri-
bution (Minimum, 1st Quartile, Median, 3rd Quartile and
Maximum) are placed on the above mentioned website.
Differences between ABPM and HBPM
In each sub-plot of Figure 2, the vertical distance be-
tween each plotting symbol and the line of equality isTable 2 HBPM (mmHg) and heart rate (beats/min) of all
available triplicates (n = 5997, average of 22.2 sets of
triplicates per subject)
Variable Mean SD Minimum Maximum
Systolic_1st 126 17 55 234
Systolic_2nd 123 16 76 200
Systolic_3rd 122 16 73 243
Diastolic_1st 78 12 28 203
Diastolic_2nd 77 11 39 165
Diastolic_3rd 77 11 37 232
Heart rate_1st 70 12 40 128
Heart rate_2nd 69 11 39 125
Heart rate_3rd 69 11 38 135the difference between ABPM and HBPM (ABPM –
HBPM) for the corresponding index of distribution for
that participant. Within each dotted rectangle in each
sub-plot there will be a set of indices of distribution
(Minimum, 1st Quartile, Median and 3rd Quartile,
Maximum) for ABPM minus HBPM. These are shown
in Figure 3. The vertical distance between the upper-
most and lowermost lines shows the span between the
maxima and minima of the respective indices of distri-
bution. It is of the order of 70 mm Hg for the 1st Quar-
tiles, Medians and 3rd Quartiles, but increased to about
130 mm Hg. For the 1st Minima and about 170 mm Hg
for the Maxima. The Minima tended to be distributed
towards negative values of (ABPM-HBPM), but towards
progressively more positive values for the Medians, 3rd
Quartiles and Maxima.
Discussion
This was a purely observational study with no intervention
and no prospective hypothesis to test. Any references to
“statistical significance” are notional rather than definitive.
Part 1: Triplicate home blood pressure measurements
There is disagreement between guidelines for self-measured
BPMs at home: (i) the European Society of Hypertension
[1] and the 2012 Canadian Hypertension Education Pro-
gram [2] recommend duplicate HBPMs in the morning
and evening; (ii) the American Society of Hypertension [3]
recommends triplicate HBPMs [4]; (iii) the Japanese So-
ciety of Hypertension recommends at least one HBPM
[5]. As reported here and elsewhere [6,7], the 1st HPPM
in a triplicate tends to be higher than the 2nd and 3rd.
The differences are quite small. The statistical signifi-
cances attached to the values in Table 2 and Table 3 arise
more from their consistency than from their size. They
amount, on average, to 3 – 4 mmHg for systolic BP,
1 mmHg for diastolic and 1 – 2 mmHg for the heart rate.
These amount respectively to about 18–25%, 9% and 9–
Figure 2 Participant-by participant plots of the indices of distribution of HBPM against the corresponding indices of distribution of ABPM.
The diagonal line is the line of equality.
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simple power calculations to obtain numbers of triplicates
needed to have 80% power to attach significance at the 5%
level gives 268 – 475 triplicates for systolic BP, 2077 –
2453 for diastolic, and 393–2077 for heart rate. The re-
peated measures element of the Friedman test that was
applied would have provided somewhat more discriminat-
ing power because it separated differences in measure-
ment within triplicate from differences between triplicates.
However the extra discriminating power was not sufficient
for the significance of the differences in diastolic pressure
and heart rate that were seen for the 5997 triplicates rep-
resented in Table 2 to be apparent also in the 270 tripli-
cates in Table 3.
Nonetheless, the differences between triplicates have
been sufficient in at least one study for the diagnosis of
“hypertension” to be made more frequently with the first
than with the mean of the 2nd and 3rd [8]. Consequently,
they may have some effect on selecting patients for inclu-
sion in trials of antihypertensive medication, or conceivablycommencement or modification of anti-hypertensive ther-
apy. However it is hardly conceivable that patients would
be started on such therapy solely on a BPM if that measure-
ment was so close to the chosen criterion that the differ-
ences in measurement in a triplicate would be crucial. The
decision would surely have to be based on a more compre-
hensive assessment of risk.
Some of the guidelines recommend discarding the higher
HBPMs that are often measured initially, but this refine-
ment had no impact in explanatory modelling of cardiovas-
cular risk [9] or organ damage [10]. In keeping with the
greater precision evident in Table 2 than in Table 3, one
would expect the precision in estimating CVR to increase
with the number of measurements contributing to the esti-
mate of BP, though possibly only up to a point. For ex-
ample, Niiranen et al. [10] found that the most precise
predictions were achieved by including all values of dupli-
cates measured twice per day over 7 days, though the mea-
surements made over the first 3 days were more influential































Figure 3 Indices of distribution of the indices of distribution of the values ABPM - HBPM.
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important. For example, in a mixture of normotensives
and hypertensive patients seen in the clinic, evening
HBPMs predicted stroke more reliably than casual HBPM
regardless of the number of measurements [11]. On the
other hand, morning HBPMs predicted stroke more reli-
ably than evening HBPMs in patients on hypertensive
medication but not in normotensive patients [12]. Like-
wise, the variability in HBPM had an additional predictive
power beyond mean systolic HBPM only in hypertensive
patients [13].
Kawabe et al. [14] reported that the 1st systolic HBPM
in morning triplicates had a larger coefficient of vari-
ation (CV) than the 2nd and was probably affected by
the subject’s gender and smoking habits. In our Tables 2
and 3, the standard deviations did not seem very differ-
ent between measurements in the triplicates.
The gender differences obtained in our small sample
were consistent with those in the review by Reckelhoff [15].Part 2: Comparison of ambulatory and home blood
pressure measurements
ABPM was developed before HBPM and remains more
copiously documented. It can also identify a larger number
of features than either clinic or HBPM (e.g. “white coat
hypertension”, night-time ABPM, the night-to-day BP ratio
and “dipping” status - which are significant predictors of
outcome [16]). It has therefore acquired ”gold standard”status though this does not necessarily mean that average
or median ABPM is, by itself, the most accurate indicator
of true normo-/hypertensive status. Unlike ABPMs, self-
measured HBPMs can only be obtained while the patient is
awake. The best agreement between ABPM and HBPM ap-
peared to be in the morning between the first HBPM of the
day and the mean of the 4 observations taken in the second
hour after the patient had wakened [17]. We have restricted
our comparison to daytime ABPMs and HBPMs.
A systematic review including six comparisons of
HBPM and ABPM found that blood pressures over the
criterion of 135/85 mmHg were obtained more fre-
quently overall with HBPMs [5]. However, in the three
studies with the largest numbers of HBPMs (29 to 56), the
average ABPMs were higher than the HBPMs, to a lesser
or greater degree. In one [18], the difference was similar to
that found in our previous study [19] with a similar num-
ber of HBPM measurements.
Our present results were from a data set that included an
average of 45 HBPM and 63 ABPM measurements per par-
ticipant. The comparison are in terms of the indices of dis-
tribution of the sets of observations of HBPM and ABPM
in each subject across a set of subjects, as illustrated in our
Figure 2 and Figure 3. For the 1st, 2nd and 3rd quartiles: (i)
increases in individual ABPMs between patients tended to
correlate reasonably well with increases of the correspond-
ing HBPMs (r close to 0.7 in plots 2, 3 and 4 in Figure 2);
(ii) ABPM tended to be greater than the corresponding
HBPM by amounts that increased with increase in BP (by
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for the 2nd and 19.5 mm Hg for the 3rd, Figure 3). At the
extremes of the distributions: (i) there was less correspond-
ence between the increases in ABPM and HBPM (r less
than 0.3 for plots 1 and 5 in Figure 2); (ii) the spans of the
distributions of the minima and maxima were wider, and
the minima of the distributions of the 1st, 2nd 3rd quartiles
were at negative values of (ABPM – HBPM, Figure 3).
It is a plausible conjecture that the behaviour of the mea-
surements at the extremes of their range may be partly due
to movement-related measurement artefacts in the ABPMs:
the subject may be less inclined to interrupt his or her ac-
tivity every 15 minutes for the duration of each ABPM
whereas he or she might be more likely to stop and be set-
tled for the HBPMs, at least by the time the 2nd and 3rd
measurement in each triplicate has been made. The relative
symmetry of both distributions in our Figure 2 about their
medians is consistent with the observation of Lijarcio [20]
who demonstrated, that for HBPM, the medians and means
are more or less interchangeable – which was corroborated
by detailed comparisons within our data set. The observa-
tions in Figure 2 are consistent with our previous observa-
tions [20] that, with duplicate HBPMs 3 times per day for a
week, the coefficient of variation of the HBPMs was smaller
than that of daytime ABPM obtained between 7 am and
10 pm on a single day, (4.2% compared with 5.5%).
Irrespective of whether it is the ABPM or HBPM that
gives a “truer” picture of whether or not a subject should
be labelled “hypertensive” at a particular time, we have
argued previously on pragmatic grounds [19] that the
smaller CVs associated with HBPM should make them
more useful for detecting sooner and more reliably if, when,
and how quickly a change in the subject’s underlying blood
pressure has taken place, whether in response to institution
or modification of treatment, or to other intercurrent influ-
ences. A further pragmatic advantage of HBPMs for longer-
term monitoring is that because of resource limitations,
facilities for ABPMs are usually only available over a shorter
time and are more intrusive on activities of daily living.
Conclusions
(1) Numbers of observations do matter.
Recommendations for types and numbers of BPM
should take into account the stringency required for
the purpose to which the BPMs are being put.
(2) A more effective harmonization of guidelines is
desirable when studying the effects of interventions
on blood pressure, not least if those studies are to be
included in systematic reviews and meta-analyses
(3) Resource limitations, and the time-scale required
for the measurements have an important bearing on
which measurement technique to use and how many
measurements to make.Competing interests
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